TenGen Biomedical (also known as USA TenGen) is a developer of early-stage vaccines and biological drugs. It uses DNA recombinant vaccine platforms to provide therapeutic and prophylactic vaccines for cervical cancer and infectious diseases. The company also delivers protein purification and analysis, lipid purification and analysis, gene recombination and expression, animal tumor models, and monoclonal antibody preparation services.